Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Silverback Therapeutics, Inc. | Sr. Vice President of Finance | Common Stock | 37.3K | $141K | $3.78 | May 2, 2022 | Direct |
Silverback Therapeutics, Inc. | Sr. Vice President of Finance | Stock Option (right to buy) | 56.7K | May 2, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRY | Silverback Therapeutics, Inc. | May 2, 2022 | 2 | $0 | 4 | May 4, 2022 | Sr. Vice President of Finance |
SPRY | Silverback Therapeutics, Inc. | Feb 1, 2022 | 3 | $0 | 4 | Feb 2, 2022 | Sr. Vice President of Finance |
SPRY | Silverback Therapeutics, Inc. | Dec 8, 2020 | 1 | $4.2K | 4/A | Feb 24, 2022 | Sr. Vice President of Finance |